TVTX
#1192
Travere Therapeutics, Inc. - Common Stock
67.5 2 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.60%
Variación mensual
+20.46%
Variación en los últimos 6 meses
+130.60%
Cambio anual
+134.69%
Cierres anteriores
67.1 2
Open
67.5 2
Mínimo
67.5 2
Máximo
67.5 2
Volumen
95
Financials
- Market Capitalization 6.36 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-131.76
Relación precio/flujo de caja
6.95
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1177 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 99.75 USD | +1.26% | +2.15% | -10.97% | +42.24% | 6.48 B USD | ||
| 1185 |  COGT Cogent Biosciences, Inc. - Common Stock | 37.09 USD | +1.01% | +3.75% | -8.80% | +136.69% | 6.44 B USD | ||
| 1200 |  LQDA Liquidia Corporation - Common Stock | 69.94 USD | -1.99% | -1.37% | -19.44% | +209.47% | 6.26 B USD | ||
| 1202 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 111.54 USD | +0.70% | +1.00% | +9.22% | +350.85% | 6.24 B USD |